The changes in hepatic glucose production (Ra), tissue glucose disposal (Rd), and plasma glucose and insulin concentration that took place over a 16-h period from 10 to 2 p.m. were documented in 14 individuals; 8 with non-insulin-dependent diabetes mellitus (NIDDM) and 6 with normal glucose tolerance. Values for Ra were higher than normal in patients with NIDDM at 10 p.m. (4.73 +/- 0.41 vs. 3.51 +/- 0.36 mg/kg per min, P less than 0.001), but fell at a much faster rate throughout the night than that seen in normal subjects. As a consequence, the difference between Ra in normal individuals and patients with NIDDM progressively narrowed, and by 2 p.m., had ceased to exist (1.75 +/- 0.61 vs. 1.67 +/- 0.47 mg/kg per min, P = NS). Plasma glucose concentration also declined in patients with NIDDM over the same period of time, but they remained quite hyperglycemic, and the value of 245 +/- 27 mg/dl at 2 p.m. was about three times greater than in normal individuals. Plasma insulin concentrations also fell progressively from 10 to 2 p.m., and were similar in both groups throughout most of the 16-h study period. Thus, the progressive decline in Ra in patients with NIDDM occurred despite concomitant falls in both plasma glucose and insulin concentration. Glucose disposal rates also fell progressively in both groups, but the magnitude of the fall was greater in patients with NIDDM. Consequently, Rd in patients with NIDDM was higher at 10 p.m. (3.97 +/- 0.48 vs. 3.25 +/- 0.13 mg/kg per min, P less than 0.001) and lower the following day at 2 p.m. (1.64 +/- 0.21 vs. 1.97 +/- 0.35 mg/kg per min, P less than 0.01). These results indicate that a greatly expanded pool size can exist in patients with NIDDM at a time when values for Ra are identical to those in normal subjects studied under comparable conditions, which suggests that fasting hyperglycemia in NIDDM is not simply a function of an increase in Ra.
Y D Chen, C Y Jeng, C B Hollenbeck, M S Wu, G M Reaven
Title and authors | Publication | Year |
---|---|---|
Circulating metabolite homeostasis achieved through mass action.
Li X, Hui S, Mirek ET, Jonsson WO, Anthony TG, Lee WD, Zeng X, Jang C, Rabinowitz JD |
Nature metabolism | 2022 |
Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion
C Solis-Herrera, G Daniele, M Alatrach, C Agyin, C Triplitt, J Adams, R Patel, A Gastaldelli, H Honka, , M Abdul-Ghani, E Cersosimo, SD Prato, R DeFronzo |
Diabetes care | 2020 |
Paradigm shifts in Nocturnal Glucose Control in Type 2 Diabetes
A Basu, N Joshi, J Miles, RE Carter, RA Rizza, R Basu |
The Journal of clinical endocrinology and metabolism | 2018 |
Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment
E Bonora, R DeFronzo |
2018 | |
Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment
E Bonora, RA DeFronzo |
2018 | |
International Textbook of Diabetes Mellitus: DeFronzo/International Textbook of Diabetes Mellitus, Fourth Edition
RN Bergman, M Ader |
International Textbook of Diabetes Mellitus: DeFronzo/International Textbook of Diabetes Mellitus, Fourth Edition | 2015 |
Comprehensive Physiology
SN Cheuvront, RW Kenefick |
Comprehensive Physiology | 2014 |
Improved Glucose Metabolism In Vitro and In Vivo by an Allosteric Monoclonal Antibody That Increases Insulin Receptor Binding Affinity
JA Corbin, V Bhaskar, ID Goldfine, DH Bedinger, A Lau, K Michelson, LM Gross, BA Maddux, HF Kuan, C Tran, L Lao, M Handa, SR Watson, AJ Narasimha, S Zhu, R Levy, L Webster, SD Wijesuriya, N Liu, X Wu, D Chemla-Vogel, SR Lee, S Wong, D Wilcock, ML White, K Maedler |
PloS one | 2014 |
ASSOCIATION OF rs9939609 FTO GENE POLYMORPHISM WITH METABOLIC SYNDROME AND ITS COMPONENTS IN RUSSIAN POPULATION
NV Khromova, OP Rotar, AM Erina, DA Shavshin, NP Alexeeva, AA Kostareva, , EV Shlyakhto |
2013 | |
Free Radicals and Metabolic Disorders
G Cohen, Y Riahi, S Sasson |
Encyclopedia of Radicals in Chemistry Biology and Materials | 2012 |
A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control
V Bhaskar, ID Goldfine, DH Bedinger, A Lau, HF Kuan, LM Gross, M Handa, BA Maddux, SR Watson, S Zhu, AJ Narasimha, R Levy, L Webster, SD Wijesuriya, N Liu, X Wu, D Chemla-Vogel, C Tran, SR Lee, S Wong, D Wilcock, ML White, JA Corbin |
Diabetes | 2012 |
The Metabolic Syndrome
S Devaraj, D Siegel, I Jialal |
The Metabolic Syndrome | 2011 |
Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009
RA DeFronzo |
Diabetologia | 2010 |
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
RA DeFronzo |
Diabetes | 2009 |
Tracer-determined glucose fluxes in health and type 2 diabetes: basal conditions
J Radziuk, S Pye |
Best Practice & Research Clinical Endocrinology & Metabolism | 2003 |
Methods for quantifying insulin resistance in human immunodeficiency virus-positive patients
JW Chu, F Abbasi, GW Beatty, M Khalili, J Koch, A Rosen, JM Schmidt, JD Stansell, GM Reaven |
Metabolism | 2003 |
Impaired oxidative phosphorylation in hepatic mitochondria in growth-retarded rats
IE Peterside, MA Selak, RA Simmons |
American journal of physiology. Endocrinology and metabolism | 2003 |
Reduction of hepatic glycogen synthesis and breakdown in patients with agenesis of the dorsal pancreas
H Stingl, WJ Schnedl, M Krssak, E Bernroider, MG Bischof, T Lahousen, G Pacini, M Roden |
The Journal of clinical endocrinology and metabolism | 2002 |
The fourth Musketeer — from Alexandre Dumas to Claude Bernard
GM Reaven |
Diabetologia | 1995 |
Anti-hyperglycaemic mechanisms of benfluorex in type II diabetes mellitus
PD Feo, GB Bolli, R Lavielle, PD Gregoris |
Diabetes/Metabolism Reviews | 1993 |
Role of insulin resistance in the pathophysiology of non-insulin dependent diabetes mellitus
GM Reaven |
Diabetes/Metabolism Reviews | 1993 |
Pathogenesis of Type 2 (non-insulin dependent) diabetes mellitus: a balanced overview
RA DeFronzo |
Diabetologia | 1992 |
Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus
L Epifano, AD Vincenzo, C Fanelli, E Porcellati, G Perriello, PD Feo, M Motolese, P Brunetti, GB Bolli |
European Journal of Clinical Pharmacology | 1992 |
Is muscle the major site of insulin resistance in Type 2 (non-insulin-dependent) diabetes mellitus?
JE Gerich |
Diabetologia | 1991 |
Acute Changes in Plasma Non-esterified Fatty Acid Concentration do not Change Hepatic Glucose Production in People with Type 2 Diabetes
P Johnston, C Hollenbeck, W Sheu, YD Chen, GM Reaven |
Diabetic Medicine | 1990 |
Physiopathologie du diabète non insulinodépendant : données actuelles et conséquences thérapeutiques
C Broussolle, J Orgiazzi, G Noël |
La Revue de Médecine Interne | 1990 |
Effect of glyburide on hepatic glucose metabolism
OP McGuinnes, AD Cherrington |
The American Journal of Medicine | 1990 |
On the determination of basal glucose production rate in patients with Type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion
O Hother-Nielsen, H Beck-Nielsen |
Diabetologia | 1990 |
Acute and chronic effects of hyperglycaemia on glucose metabolism
H Yki-Jrvinen |
Diabetologia | 1990 |
Inhibition of apolipoprotein B net synthesis and secretion from cultured rat hepatocytes by the calcium-channel blocker diltiazem
TC Kwong, JD Sparks, DJ Pryce, JF Cianci, CE Sparks |
Biochemical Journal | 1989 |
Metabolic basis of obesity and noninsulin-dependent diabetes mellitus
A Golay, JP Felber, E Jequier, RA DeFronzo, E Ferrannini |
Diabetes / Metabolism Reviews | 1988 |
Insulin Resistance
A Voll, J Kloster |
Acta Medica Scandinavica | 1957 |